A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

NCT00401570 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Volociximab
DRUG: Gemcitabine

Sponsor

AbbVie (prior sponsor, Abbott)